Pharmaceutical News

RSS

Antidepressant use soars among people aged 65 and over

A study had found that there has been a rise in antidepressant use in people aged 65 and over, even though numbers of those depressed has not changed.

7 Oct 2019

EIB and Univercells sign EUR 20 million loan agreement to advance delivery of vaccines

The European Investment Bank and Univercells S.A have signed a EUR 20 million loan agreement to support the development of a portfolio of four essential and undersupplied vaccines to be delivered at an affordable price.

4 Oct 2019

Kibow Biotech celebrates 22nd anniversary with plans to expand its product portfolio

Kibow® Biotech Inc, a pioneering probiotic company in gut modulation with its novel "Enteric Dialysis®" technology platform, is celebrating its 22-year anniversary on October 1st, 2019.

From Kibow Biotech Inc. 4 Oct 2019

Innovative drug treatment developed for familial adenomatous polyposis

Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.

3 Oct 2019

Common gout medications can kill elephantiasis-causing parasites

Treatment with two common FDA-approved gout medications have been found to cause rapid death to the parasites that cause elephantiasis.

3 Oct 2019

4 out of 5 people on antidepressant drugs are unaware of the side effects

New research has found that less than half of practitioners have mental health training and thousands of patients are left in the dark about their medications.

3 Oct 2019

Fewer than half of U.S. adults get annual flu shot, shows study

So far this calendar year, 1,243 people scattered around 31 states had confirmed measles, the highest number of measles cases reported in the U.S.

3 Oct 2019

Aspirin may reduce adverse effects of air pollution exposure on lung function

A new study is the first to report evidence that nonsteroidal anti-inflammatory drugs like aspirin may lessen the adverse effects of air pollution exposure on lung function.

3 Oct 2019

Study: Aspirin is not recommended for people who never had a heart attack or stroke

If you've never had a heart attack or stroke, you likely should not be taking aspirin to prevent them, according to new research.

3 Oct 2019

Entos Pharmaceuticals signs new collaboration agreement with biopharmaceutical company

Entos Pharmaceuticals Inc. ("Entos" or the "Company"), a healthcare biotechnology company focused on the development of next-generation nucleic acid-based therapies using their Fusogenix drug delivery platform, today announced it has entered into a research, development and collaboration agreement ("Agreement") with a clinical stage biopharmaceutical company ("Partner") focused on the development of novel therapeutic compounds targeting autoimmune and inflammatory diseases.

3 Oct 2019

First-of-its-kind study shows antidepressants are safe

Antidepressants are safe, with adverse effects generally being due to existing psychiatric conditions, according to new research.

2 Oct 2019

Researchers find no evidence of adverse health outcomes linked with antidepressant use

Antidepressants are generally safe, according to a new study by an international team of researchers. By assessing evidence from 45 meta-analyses, which combined the results from many studies, the researchers did not find strong evidence of adverse health outcomes associated with antidepressant use.

2 Oct 2019

Heart failure medication often prescribed in lower dosages than recommended

Important medication for the treatment of heart failure are often prescribed in lower dosages than recommended by international guidelines.

1 Oct 2019

Mount Sinai researchers receive NIH award to develop universal flu vaccine

Researchers at the Icahn School of Medicine at Mount Sinai have received a contract award of up to $132 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), as part of a new Collaborative Influenza Vaccine Innovation Centers (CIVICs) program to further develop the universal flu vaccine.

1 Oct 2019